Module Innovations
Module Innovations is a Pune-based deeptech company developing the patented SDSAN platform for ultra-rapid diagnostics of infectious diseases and antimicrobial resistance, serving hospitals, clinics, and clinicians with tools to guide timely antibiotic treatment.
- Company typePrivate
- Founded2014
- HeadquartersPune, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Module Innovations does
Module Innovations is a Pune, India-based deeptech company founded in 2014 that develops ultra-rapid diagnostic devices targeting infectious diseases and antimicrobial resistance (AMR). The company serves healthcare providers, hospitals, and clinicians who need faster diagnostic results to guide timely and appropriate antibiotic treatment decisions. AMR is positioned as a critical and growing global health threat, with the company citing projections of 10 million deaths annually by 2050, framing the market need it aims to address.
The company's core offering is its patented SDSAN technology platform, a proprietary diagnostic method architecture that delivers rapid and accurate results for infectious disease and AMR testing. Module Innovations is the sole named product, and the platform is positioned as a foundation for ultra-rapid diagnostics. The company is privately held, has 11-50 employees, and holds a registered/granted patent on the SDSAN technology. Leadership comprises four named co-founders: Sachin Dubey (CEO), Usman Khan (COO), Mohit Dubey (Chief Designer), and Rahul Chaudhari (CTO).
The business model is not fully disclosed; no pricing, revenue figures, named customers, or distribution channels are publicly available. The company has raised a $3.2 million grant from CARB-X in March 2020 and an earlier round from Venture Center in 2016, and it is supported by unnamed leading deeptech funders. There is no public evidence of commercial sales, regulatory clearances, or named healthcare deployments, suggesting the company is in a pre-commercial or early pilot stage with its commercial infrastructure still under development.
Module Innovations firmographics
Firmographics- Name
- Module Innovations
- Legal name
- Module Innovations
- Website
- https://moduleinnovations.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Module Innovations is a Pune-based deeptech company developing the patented SDSAN platform for ultra-rapid diagnostics of infectious diseases and antimicrobial resistance, serving hospitals, clinics, and clinicians with tools to guide timely antibiotic treatment.
- Ownership category
- akta.pro rank
Module Innovations industry classification
Industry- Product category
- Infectious Disease Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
- akta.pro secondary industry
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
Keywords
Where Module Innovations is headquartered
LocationHeadquarters
- HQ city
- Pune
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Module Innovations business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations
Module Innovations product offering
Product offeringCore offering
Module Innovations develops affordable diagnostic devices for ultra-rapid detection of microbes from clinical and non-clinical samples, using its patented SDSAN technology platform. The company's products target infectious disease and Antimicrobial Resistance (AMR) testing, enabling clinicians to make timely antibiotic treatment decisions by reducing diagnostic delays.
Product overview
Module Innovations offers a single unified diagnostic technology platform built on its patented SDSAN technology. The platform focuses on ultra-rapid diagnostics for infectious diseases and Antimicrobial Resistance (AMR), providing clinicians with rapid and accurate diagnostic tools that reduce diagnostic delays and enable timely antibiotic treatment decisions to improve patient outcomes.
Differentiator
Problem solved
Functional benefit
Products and services
- SDSAN Technology Platform Patented SDSAN technology platform designed for ultra-rapid diagnostics of infectious diseases and Antimicrobial Resistance (AMR) from clinical and non-clinical samples, providing clinicians with rapid and accurate diagnostic results to support timely antibiotic treatment decisions.
Companies that use Module Innovations
Customer profileSegments1 record
Ideal customer profiles1 record
Module Innovations technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Module Innovations partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Module Innovations competitors and assessment
Company assessmentDirect peers
- Accelerate Diagnostics: Develops rapid automated ID/AST systems (e.g., Pheno system) for bloodstream infections and AMR. Directly comparable to Module's SDSAN value proposition of fast phenotypic antimicrobial susceptibility results from clinical samples.
- Specific Diagnostics: Developer of the Reveal rapid AST system using proprietary sensor technology to deliver phenotypic susceptibility in hours. Closely comparable in mission — ultra-rapid AST to support antibiotic stewardship — and in technology architecture (novel sensing for AST).
- Q-linea: Swedish IVD company with the ASTar rapid ID/AST system targeting bloodstream infections and AMR. Competes head-to-head with Module's SDSAN on speed-to-AST and the same clinical customer (hospital microbiology labs).
- QuantaMatrix: Developer of rapid phenotypic AST using microfluidic single-cell imaging (dRAST). Same 'ultra-rapid ID/AST from positive blood culture' use case as Module and similar ambition to displace multi-day conventional AST.
- T2 Biosystems: T2 Magnetic Resonance-based rapid diagnostics for sepsis-causing pathogens and AMR. Competes for the same clinical decision point (early targeted therapy for bloodstream infections) with a different but related rapid-platform architecture.
Broad incumbents
- bioMérieux: Global leader in microbiology diagnostics (VITEK, BACT/ALERT, BioBall) with established hospital sales channels. Not a direct product overlap with SDSAN, but the dominant incumbent whose installed base Module must displace for AMR-testing contracts.
- BD (Becton Dickinson) — Diagnostic Systems: BD Phoenix M50 and BD MAX systems cover ID/AST and molecular diagnostics across hospital networks. A broad incumbent whose microbiology portfolio overlaps directly with Module's target segment and whose scale and contracts set the competitive bar.
- Cepheid (Danaher): GeneXpert molecular diagnostic platform widely installed in hospital labs, including resistance-gene panels. Comparable end-customer and clinical use case (rapid ID with AMR markers), with much broader installed footprint.
Regional players
- Molbio Diagnostics: India-based molecular diagnostics company (Truenat, Truelab) with strong public-health and Indian hospital penetration. Closest geographic peer and the most likely Indian-market competitor or commercialization partner for Module.
Emerging players
- Curetis (OpGen): Molecular microbiology and AMR-focused diagnostics (Unyvero, Acuitas AMR Gene Panel). Smaller, niche player with overlapping AMR focus and hospital-lab customer base; useful comparable for Module's go-to-market trajectory.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Module Innovations social profiles
Digital presenceModule Innovations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Module Innovations leadership team
Management profileNumber of profiles
Profiles4 records
Module Innovations funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Module Innovations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Module Innovations
What does Module Innovations do?
Module Innovations develops affordable diagnostic devices for ultra-rapid detection of microbes from clinical and non-clinical samples, using its patented SDSAN technology platform. The company's products target infectious disease and Antimicrobial Resistance (AMR) testing, enabling clinicians to make timely antibiotic treatment decisions by reducing diagnostic delays.
Is Module Innovations a public or private company?
Module Innovations is a private company. It is classified as venture growth investor backed and is currently operating.
When was Module Innovations founded?
Module Innovations was founded in 2014. It employs 11 to 50 people.
Where is Module Innovations based?
Module Innovations is headquartered in Pune, India, in the Asia region.
Who are Module Innovations's main competitors?
Direct peers on record are Accelerate Diagnostics, Specific Diagnostics, Q-linea, QuantaMatrix and T2 Biosystems. Broad incumbents are bioMérieux, BD (Becton Dickinson) — Diagnostic Systems and Cepheid (Danaher). Molbio Diagnostics is listed as a regional player. Curetis (OpGen) is listed as an emerging player.
Does Module Innovations have an API?
No public API is recorded for Module Innovations.
What industry is Module Innovations in?
Module Innovations's product category is Infectious Disease Diagnostics. Its primary akta.pro industry code is HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 325413 and its SIC code is 2835.